Hyperrab 300 unit/ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0MQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,298
Award facts
- Contract value 100% obligated
- $3,298.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded February 4, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, calls for the delivery of HYPERRAB 300 Unit/mL vial 5mL units with a ceiling value of $3,298.22 and a completion date of February 26, 2026. The award is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HYPERRAB is an immunoglobulin product used for rabies post-exposure prophylaxis, representing a critical pharmaceutical commodity within the federal medical supply chain.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies to military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill such federal medical procurement needs through its established relationships with the Defense Health Agency and military treatment facilities.
Quick answers
Who was awarded contract SPE2DR26F0MQ4?
SPE2DR26F0MQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F0MQ4 worth?
The government has obligated $3,298 on SPE2DR26F0MQ4.
Is contract SPE2DR26F0MQ4 an order under another contract?
Yes. SPE2DR26F0MQ4 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0MQ4 competed?
The extent of competition for SPE2DR26F0MQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award